Literature DB >> 33200441

The Challenge of Peptide Proteolytic Stability Studies: Scarce Data, Difficult Readability, and the Need for Harmonization.

Marco Cavaco1,2, David Andreu2, Miguel A R B Castanho1.   

Abstract

Proteolytic stability assessment is increasingly viewed as a fundamental component of peptide characterization, arguably of comparable importance as efficacy and toxicity data. A literature survey over the last decade reveals steady growth in the stability information available. However, it also uncovers two significant problems that hinder proper data comparison: 1) the use of different stability assays, and 2) the differences in how stability information is reported. In this Viewpoint, we present results from a database meta-analysis as well as concerns about the stability assessments published so far. We also suggest guidelines for a proper discussion between experts in the field on how to improve data readability so that peptide stability, an often-missing parameter in older literature, is adequately reported to take maximum advantage of it.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  degradation; peptides; proteolysis; stability

Year:  2020        PMID: 33200441     DOI: 10.1002/anie.202006372

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  9 in total

1.  Identification and Characterization of a Potential Antimicrobial Peptide Isolated from Soil Brevibacillus sp. WUL10 and Its Activity against MRSA Pathogens.

Authors:  Apichart Atipairin; Nuttapon Songnaka; Sucheewin Krobthong; Yodying Yingchutrakul; Thapanee Chinnawong; Thamonwan Wanganuttara
Journal:  Trop Med Infect Dis       Date:  2022-06-07

2.  On the Utility of Chemical Strategies to Improve Peptide Gut Stability.

Authors:  Thomas Kremsmayr; Aws Aljnabi; Juan B Blanco-Canosa; Hue N T Tran; Nayara Braga Emidio; Markus Muttenthaler
Journal:  J Med Chem       Date:  2022-04-14       Impact factor: 8.039

Review 3.  Fungal Proteases as Emerging Biocatalysts to Meet the Current Challenges and Recent Developments in Biomedical Therapies: An Updated Review.

Authors:  Muhammad Naeem; Saba Manzoor; Mashhud-Ul-Hasan Abid; Muhammad Burhan Khan Tareen; Mirza Asad; Sajida Mushtaq; Nazia Ehsan; Dua Amna; Baojun Xu; Abu Hazafa
Journal:  J Fungi (Basel)       Date:  2022-01-24

4.  Conjugation of a Blood Brain Barrier Peptide Shuttle to an Fc Domain for Brain Delivery of Therapeutic Biomolecules.

Authors:  Marco Cavaco; Silvia Frutos; Paula Oliete; Javier Valle; David Andreu; Miguel A R B Castanho; Miquel Vila-Perelló; Vera Neves
Journal:  ACS Med Chem Lett       Date:  2021-09-02       Impact factor: 4.632

Review 5.  Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies.

Authors:  Valentina Del Genio; Rosa Bellavita; Annarita Falanga; Katel Hervé-Aubert; Igor Chourpa; Stefania Galdiero
Journal:  Pharmaceutics       Date:  2022-06-10       Impact factor: 6.525

6.  Estimating peptide half-life in serum from tunable, sequence-related physicochemical properties.

Authors:  Marco Cavaco; Javier Valle; Isabel Flores; David Andreu; Miguel A R B Castanho
Journal:  Clin Transl Sci       Date:  2021-02-28       Impact factor: 4.689

Review 7.  Protease-Resistant Peptides for Targeting and Intracellular Delivery of Therapeutics.

Authors:  Maria C Lucana; Yolanda Arruga; Emilia Petrachi; Albert Roig; Roberta Lucchi; Benjamí Oller-Salvia
Journal:  Pharmaceutics       Date:  2021-12-02       Impact factor: 6.321

Review 8.  Peptide Affinity Chromatography Applied to Therapeutic Antibodies Purification.

Authors:  Gabriela R Barredo-Vacchelli; Silvana L Giudicessi; María C Martínez-Ceron; Osvaldo Cascone; Silvia A Camperi
Journal:  Int J Pept Res Ther       Date:  2021-10-19       Impact factor: 1.931

Review 9.  The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections.

Authors:  Marco Cavaco; Miguel A R B Castanho; Vera Neves
Journal:  Front Microbiol       Date:  2022-03-07       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.